MRSN Annual CAPEX
$2.17 M
-$29.00 K-1.32%
31 December 2023
Summary:
As of January 22, 2025, MRSN annual capital expenditures is $2.17 million, with the most recent change of -$29.00 thousand (-1.32%) on December 31, 2023. During the last 3 years, it has risen by +$1.70 million (+358.35%). MRSN annual CAPEX is now -1.32% below its all-time high of $2.20 million, reached on December 31, 2022.MRSN CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRSN Quarterly CAPEX
$0.00
$0.000.00%
30 September 2024
Summary:
As of January 22, 2025, MRSN quarterly capital expenditures is $0.00, unchanged on September 30, 2024. Over the past year, it has dropped by -$472.00 thousand (-100.00%). MRSN quarterly CAPEX is now -100.00% below its all-time high of $911.00 thousand, reached on March 31, 2023.MRSN Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRSN TTM CAPEX
$518.00 K
-$472.00 K-47.68%
30 September 2024
Summary:
As of January 22, 2025, MRSN TTM capital expenditures is $518.00 thousand, with the most recent change of -$472.00 thousand (-47.68%) on September 30, 2024. Over the past year, it has dropped by -$2.05 million (-79.82%). MRSN TTM CAPEX is now -81.36% below its all-time high of $2.78 million, reached on March 31, 2023.MRSN TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRSN CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1.3% | -100.0% | -79.8% |
| 3 y3 years | +358.4% | -100.0% | -79.8% |
| 5 y5 years | +58.3% | -100.0% | -79.8% |
MRSN CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -1.3% | +234.6% | -100.0% | -81.4% | at low | |
| 5 y | 5-year | -1.3% | +358.4% | -100.0% | -81.4% | +342.7% | |
| alltime | all time | -1.3% | +358.4% | -100.0% | +100.0% | -81.4% | +342.7% |
Mersana Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $0.00(0.0%) | $518.00 K(-47.7%) |
| June 2024 | - | $0.00(-100.0%) | $990.00 K(-28.7%) |
| Mar 2024 | - | $132.00 K(-65.8%) | $1.39 M(-35.9%) |
| Dec 2023 | $2.17 M(-1.3%) | $386.00 K(-18.2%) | $2.17 M(-15.5%) |
| Sept 2023 | - | $472.00 K(+18.3%) | $2.57 M(+1.8%) |
| June 2023 | - | $399.00 K(-56.2%) | $2.52 M(-9.3%) |
| Mar 2023 | - | $911.00 K(+16.1%) | $2.78 M(+26.5%) |
| Dec 2022 | $2.20 M(+239.0%) | $785.00 K(+84.3%) | $2.20 M(+40.2%) |
| Sept 2022 | - | $426.00 K(-35.2%) | $1.57 M(+32.0%) |
| June 2022 | - | $657.00 K(+99.7%) | $1.19 M(+37.5%) |
| Mar 2022 | - | $329.00 K(+112.3%) | $863.00 K(+33.2%) |
| Dec 2021 | $648.00 K(+37.0%) | $155.00 K(+237.0%) | $648.00 K(-4.8%) |
| Sept 2021 | - | $46.00 K(-86.2%) | $681.00 K(-18.0%) |
| June 2021 | - | $333.00 K(+192.1%) | $830.00 K(+59.0%) |
| Mar 2021 | - | $114.00 K(-39.4%) | $522.00 K(+10.4%) |
| Dec 2020 | $473.00 K | $188.00 K(-3.6%) | $473.00 K(+66.0%) |
| Sept 2020 | - | $195.00 K(+680.0%) | $285.00 K(+143.6%) |
| June 2020 | - | $25.00 K(-61.5%) | $117.00 K(-60.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $65.00 K(>+9900.0%) | $298.00 K(-50.7%) |
| Dec 2019 | $605.00 K(-55.8%) | $0.00(-100.0%) | $605.00 K(-31.4%) |
| Sept 2019 | - | $27.00 K(-86.9%) | $882.00 K(-21.8%) |
| June 2019 | - | $206.00 K(-44.6%) | $1.13 M(-23.5%) |
| Mar 2019 | - | $372.00 K(+34.3%) | $1.48 M(+7.7%) |
| Dec 2018 | $1.37 M(+19.9%) | $277.00 K(+1.5%) | $1.37 M(-24.0%) |
| Sept 2018 | - | $273.00 K(-50.6%) | $1.80 M(+10.3%) |
| June 2018 | - | $553.00 K(+107.1%) | $1.64 M(+74.1%) |
| Mar 2018 | - | $267.00 K(-62.4%) | $939.00 K(-17.8%) |
| Dec 2017 | $1.14 M(+5.4%) | $710.00 K(+576.2%) | $1.14 M(+538.5%) |
| Sept 2017 | - | $105.00 K(-173.4%) | $179.00 K(+33.6%) |
| June 2017 | - | -$143.00 K(-130.4%) | $134.00 K(-88.4%) |
| Mar 2017 | - | $471.00 K(-285.4%) | $1.16 M(+7.0%) |
| Dec 2016 | $1.08 M(+75.1%) | -$254.00 K(-523.3%) | $1.08 M(-19.0%) |
| Sept 2016 | - | $60.00 K(-93.2%) | $1.34 M(+4.7%) |
| June 2016 | - | $883.00 K(+123.5%) | $1.28 M(+223.5%) |
| Mar 2016 | - | $395.00 K | $395.00 K |
| Dec 2015 | $619.00 K | - | - |
FAQ
- What is Mersana Therapeutics annual capital expenditures?
- What is the all time high annual CAPEX for Mersana Therapeutics?
- What is Mersana Therapeutics annual CAPEX year-on-year change?
- What is Mersana Therapeutics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Mersana Therapeutics?
- What is Mersana Therapeutics quarterly CAPEX year-on-year change?
- What is Mersana Therapeutics TTM capital expenditures?
- What is the all time high TTM CAPEX for Mersana Therapeutics?
- What is Mersana Therapeutics TTM CAPEX year-on-year change?
What is Mersana Therapeutics annual capital expenditures?
The current annual CAPEX of MRSN is $2.17 M
What is the all time high annual CAPEX for Mersana Therapeutics?
Mersana Therapeutics all-time high annual capital expenditures is $2.20 M
What is Mersana Therapeutics annual CAPEX year-on-year change?
Over the past year, MRSN annual capital expenditures has changed by -$29.00 K (-1.32%)
What is Mersana Therapeutics quarterly capital expenditures?
The current quarterly CAPEX of MRSN is $0.00
What is the all time high quarterly CAPEX for Mersana Therapeutics?
Mersana Therapeutics all-time high quarterly capital expenditures is $911.00 K
What is Mersana Therapeutics quarterly CAPEX year-on-year change?
Over the past year, MRSN quarterly capital expenditures has changed by -$472.00 K (-100.00%)
What is Mersana Therapeutics TTM capital expenditures?
The current TTM CAPEX of MRSN is $518.00 K
What is the all time high TTM CAPEX for Mersana Therapeutics?
Mersana Therapeutics all-time high TTM capital expenditures is $2.78 M
What is Mersana Therapeutics TTM CAPEX year-on-year change?
Over the past year, MRSN TTM capital expenditures has changed by -$2.05 M (-79.82%)